Stifel Downgrades Bio-Techne to Hold, Announces $65 Price Target
Portfolio Pulse from Benzinga Newsdesk
Stifel analyst Daniel Arias downgraded Bio-Techne (NASDAQ:TECH) from Buy to Hold and set a new price target of $65.

February 02, 2024 | 11:41 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Stifel downgraded Bio-Techne to Hold and set a $65 price target.
Analyst downgrades typically lead to a negative short-term reaction in the stock price as they suggest a less optimistic outlook on the company's future performance. The setting of a specific price target provides a benchmark that can influence investor expectations and market sentiment towards the stock.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100